According to the in-depth research report published by MarkNtel Advisors, the United Kingdom Soft Gelatin Capsules Market is expected to grow at a CAGR of 5.8% during 2026--2032. The market growth is ...

Vazalore is indicated as a pain reliever, fever reducer, and for aspirin therapy indications. The Food and Drug Administration (FDA) has approved the supplemental New Drug Applications (sNDAs) for ...

A phase I study of ombrabulin (O) combined with bevacizumab (B) in patients with advanced solid tumors (NCT01193595). A phase I study of R04929097, an oral gamma secretase inhibitor, in combination ...

Twenty-four healthy subjects (12 male and 12 female) were included in the trial. They were aged between 22 and 45 (mean 34.4) years, and had body mass indexes of 19.0-28.8 (mean 24.7) kg/m 2. Major ...

An important element of many manufacturing processes in the pharmaceutical industry is the blending of a small amount of Active Pharmaceutical Ingredient (API) with a bulk excipient, and then ...

Softgel Capsules Market · GlobeNewswire Inc. Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "Softgel Capsules Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering.

A 2026 informational overview of the SonusZen hearing support formulation, Sonus Zen ingredient transparency and B vitamin research context, tinnitus supplement category positioning, auditory health ...

Please provide your email address to receive an email when new articles are posted on . The FDA has given final approval to Perrigo Co.’s miniature 20 mg delayed-release omeprazole magnesium capsules ...

The Company has not disclosed a reason for the medication discontinuation, however in 2017, the FDA reported that olaparib capsules were being phased out of the US market. [UPDATE 9/6/18] Lynparza ...

LYON, France--(BUSINESS WIRE)--MaaT Pharma announced today that it treated its first patient in a Phase 1 clinical trial to evaluate the safety and tolerability of MaaT033, a capsule formulation of ...